HER2-POSITIVE ADVANCED BREAST CANCER
Clinical trials for HER2-POSITIVE ADVANCED BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE ADVANCED BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2-POSITIVE ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted combo aims to replace chemo in HER2+ breast cancer
Disease control OngoingThis Phase 3 trial tests whether a combination of targeted drugs (trastuzumab, alpelisib, and possibly fulvestrant) can work better than standard chemotherapy for people with a specific genetic mutation (PIK3CA) in HER2+ advanced breast cancer. The study enrolled 27 participants …
Matched conditions: HER2-POSITIVE ADVANCED BREAST CANCER
Phase: PHASE3 • Sponsor: Spanish Breast Cancer Research Group • Aim: Disease control
Last updated Jun 26, 2026 15:03 UTC
-
New study: can a pill stop chemo nausea in advanced breast cancer?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether the anti-nausea drug NEPA (netupitant/palonosetron) can prevent vomiting and nausea in people with advanced HER2-positive or HER2-low breast cancer who are receiving the drug T-DXd. It will follow 100 participants across multiple hospitals to see how w…
Matched conditions: HER2-POSITIVE ADVANCED BREAST CANCER
Sponsor: Yeon Hee Park • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC